Does upper airway deformation affect drug deposition?

Int J Pharm. 2019 Dec 15:572:118773. doi: 10.1016/j.ijpharm.2019.118773. Epub 2019 Oct 31.

Abstract

Knowledge that enables the accurate simulation of drug deposition in the human upper airway is necessary to develop robust platforms for efficient drug delivery by inhalation devices. The human upper airway is deformable during inhalation but how it could affect the deposition of inhaled drugs is unknown. We aimed to determine whether pharyngeal deformation at the soft palate level would have any significant effects on throat deposition, in vitro lung dose and fine particle fraction. In this study, dry mannitol powders were delivered to the next-generation cascade impactor (NGI) through the United States Pharmacopeia (USP) throat, and a realistic upper airway cast (RUPAC) at flow rates of 40, 60 and 80 L min-1. Deformation of the upper airway at 25%, 50%, and 75% in the lateral and antero-posterior directions were experimentally simulated in the RUPAC. Throat deposition (p = 0.04) is significantly affected when the upper airway deforms laterally but not antero-posteriorly.

Keywords: Fine particle fraction; In vitro lung dose; Pharynx collapse; Throat deposition; Upper airway deformation.

MeSH terms

  • Administration, Inhalation
  • Aerosols / metabolism*
  • Drug Delivery Systems / methods
  • Dry Powder Inhalers / methods
  • Female
  • Humans
  • Lung / metabolism*
  • Middle Aged
  • Particle Size
  • Pharynx / metabolism*
  • Powders / administration & dosage
  • Powders / metabolism*

Substances

  • Aerosols
  • Powders